Call for Proposals for Alfred Müller Award for Brain Tumor Research
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the accounting firm Ernst & Young jointly solicit applications for the € 10,000 Alfred Müller Award which recognizes outstanding scientific publications in neurooncology.
Alfred Müller, Picture: Ernst & Young
© dkfz.de
The Alfred Müller Award is designed to distinguish promising young scientists aged up to 40 who have published a pioneering work in the area of neurooncology in the past two years. Scientific publications from Germany, Austria and Switzerland will be considered. The focus should be on the successful transfer of research results into potential clinical applications. It is permitted to submit several publications with related content. For a single publication with multiple authors, please specify the candidate’s contribution to the publication.
Proposals for nominees may be submitted by the scientific head of the candidate’s home institute by June 30, 2011. Applications are requested to comprise a copy of the publication(s), brief Curriculum Vitae of the scientist, his or her publication list of the past five years including impact factors, and two testimonials by qualified scientists.
Please send application packages to the Chairman of the Management Board of the German Cancer Research Center, Prof. Dr. Otmar D. Wiestler (O.Wiestler@dkfz.de).
The award-winning publications will be selected by a panel of experts. The award will be presented at the “Entrepreneur Of The Year” event. Legal recourse is excluded.
Alfred Müller was a member of the managing board of the accounting and consulting firm Ernst & Young for many years. In this function he particularly promoted the company’s focus on life sciences. In doing so, he actively supported basic research and emphasized its importance for developing new treatments. Müller was diagnosed with a brain tumor in 2008 and died of this disease in the same year. Ernst & Young and DKFZ have established the Alfred Müller Award as a lasting way to commemorate him.
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.
